Notícias do Mercado de Ações
Últimas notícias financeiras · Atualizado Mai 24, 2026
Truist Abaixa PT sobre Fifth Third Bancorp (FITB), Mantém Classificação de Compra
Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …
JD.com (JD) e BYD Entram em uma Parceria Estratégica
JD.com (JD) and BYD Enters a Strategic Partnership
The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …
Morgan Stanley Mantém uma Categoria de Compra para a Block (XYZ)
Morgan Stanley Maintains a Buy on Block (XYZ)
The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …
O Teto de US$ 2.000 para Medicamentos Está Economizando Mais de US$ 1.500 por Ano para Aposentados do Medicare Agora
The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now
The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …
Huntington Bancshares (HBAN) Apresenta-se na Conferência RBC 2026, Veja o Que Você Precisa Saber
Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …
Stellantis (STLA) Considerando Parcerias Com Fabricantes Automotivos Chineses
Stellantis (STLA) Considering Partnerships With Chinese Automakers
The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …
Ações dos EUA sobem bem em relação aos piores níveis, mas ainda fecham em baixa
U.S. Stocks Climb Well Off Worst Levels But Still Close Lower
The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …
Como o Desempenho das Ações da Baxter se Compara com Outras Ações de Dispositivos Médicos?
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?
The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …
G2 Investment Partners Inicia uma Nova Posição em Xometry
G2 Investment Partners Initiates a New Position in Xometry
Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …
SBSW Atravessa Notável Nível de Baixa Abaixo da Média Móvel Crítica
SBSW Makes Notable Cross Below Critical Moving Average
The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …
BioMarin Pharmaceutical (BMRN) Reporta Resultados Positivos dos Ensaios Clínicos em Andamento do VOXZOGO
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …
Será que o Novo Plano de Defesa Aérea da Grécia Impulsionará as Ações da Lockheed Martin?
Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?
The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …